Navigation Links
NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
Date:4/8/2013

ive translation adjustment(190)(150)Total stockholders' deficit(16,073)(52,173)Total liabilities, redeemable common stock and stockholders' deficit$

7,570$

212 

 NORTHWEST BIOTHERAPEUTICS, INC.(A Development Stage Company)CONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except per share data)Years Ended December 31,Period from
Inception (March 18,
1996) to20122011December 31, 2012Revenues:Research material sales$

-$

10$

580Contract research and development from related parties--1,128Research grants and other772-1,833Total revenues772103,541Operating cost and expenses:Cost of research material sales--382Research and development28,90813,452119,172General and administration15,67513,33590,999Depreciation and amortization14102,377Loss on facility sublease--895Asset impairment loss--2,445Total operating costs and expenses44,59726,797216,270Loss from operations(43,825)(26,787)(212,729)Other income (expense):Valuation of reclassified equity instruments4918,82116,071Conversion inducement expense(9,103)(7,944)(27,337) Accretion of redeemable securities(2,042)-(2,042)Derivative valuation gain/(loss)6017281,383Gain on sale of intellectual property and property and equipment--3,664Interest expense(13,442)(7,648)(55,006)Interest income and other--1,707Net loss(67,320)(32,830)(274,289)Issuance of common stock in connection with elimination of Series A and Series A-1  preferred stock preferences--(12,349)Modification of Series A preferred stock warrants--(2,306)Modification of Series A-1 preferred stock warrants--(16,393)Series A preferred stock dividends--(334)Series A-1 preferred stock dividends--(917)Warrants issued on Series A and Series A-1 preferred stock dividends--(4,664)Accretion of Series A preferred stock mandatory redemption obligation--(1,872)Series A preferred stock redemption fee--(1,700)Beneficial conversion feature of Series D preferred stock--(4,274)Net loss applicable to common stock
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
2. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
3. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
4. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
5. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
6. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
7. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
8. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
9. Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
10. Palatin Technologies To Present At The 25th Annual ROTH Conference
11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... advanced testing solutions for the detection of foodborne ... three months and full year ended December 31, ... for the quarter ended December 31, 2014 was ... quarter of 2013 and $1.5 million for the ...
(Date:3/26/2015)...  BioNano Genomics, Inc., the leader in genome mapping, ... chief commercial officer. Salyer has more than 20 years ... life sciences. At BioNano, Salyer will oversee the commercialization ... to assemble a comprehensive view of complex genomes to ... institutions located in the United States ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 ReliantHeart, Inc., ... and Transonic, a supplier of precision transit-time flow measurement ... will greatly improve the efficiency of the HeartAssist5® ... LVAD patients to experience greater mobility and peace of ... the miniature flow board, will draw 1/6th of the ...
(Date:3/25/2015)... market is one of the most attractive in the ... plus a growing economy and increasing government investment in ... The Russian market is set to grow at twice ... estimates around 10-15% annually reaching an approximate market value ... Cross Green Cross provides total healthcare solutions ...
Breaking Biology Technology:Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3
... Commence the Marketing ... Oncology Market, BASKING RIDGE, N.J., March 28 ... Inc. (MBTG) announced today that it has received an,$88,000 ... recently,announced distribution agreement with Ferring, Inc. of Canada. Ferring,Inc. ...
... TVM Capital Joins Investor Syndicate, VIENNA, ... company developing novel antibodies and antibody fragments,based ... today that it,has acquired future royalty obligations ... payment., Modular Antibody Technology was originally ...
... /PRNewswire/ -. Actavis Group, the,international generic pharmaceuticals ... separate approvals from the U.S. Food & ... (SR). Distribution,of the products will commence immediately., ... in,150mg strength, are the generic equivalent of ...
Cached Biology Technology:Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract 2Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract 3Antibody Engineering Company F-Star Buys Back Royalty Obligations 2Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S. 2
(Date:3/23/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), a ... announces its biometric payment technology, the Wocket® smart wallet, will ... 30 th . The new 30 ... markets. Gino Pereira , ... ad campaign following the recent initial shipment of Wocket smart ...
(Date:3/20/2015)... Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the addition ... report to their offering. This report analyzes ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has ... Strategic Business Report" report to their offering. ... US$ Thousands. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... and metabolism, exerts a strong effect on appetite by ... the hypothalamus, according to a Yale School of Medicine ... regulate the ventral tegmental area (VTA) of the mid-brain ... of metabolic signals in the brain," said the senior ...
... technology for the first time ever to measure sexual arousal rates ... than men on its head. ... we see that there is no difference in the amount of ... arousal," said Dr. Irv Binik, psychology professor and founder and director ...
... of Medicine and Public Health has discovered a new part ... vessels, or angiogenesis. , The finding may help halt ... author on the study, a professor of pharmacology and member ... , The research, published in the Journal of Cell Biology ...
Cached Biology News:Thermal imaging shatters arousal gender gap myth 2New angiogenesis finding may help fight cancer growth 2New angiogenesis finding may help fight cancer growth 3New angiogenesis finding may help fight cancer growth 4
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Sheep polyclonal to Streptomycin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule: Streptomycin conjugated to BSA....
Anti-ADAM-12 (Meltrin Alpha); amino terminal region; rabbit host...
... Rabbit monoclonal [EP282Y] to Asparagine ... all tested applications). ... corresponding to residues in the ... Entrez GeneID: ...
Biology Products: